Zimmer Biomet extends TMINI deal while Zimmer Biomet stock trades at EUR 81.90

Published on 10/15/2026 at 13:17 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Zimmer Biomet stock costs EUR 81.90 on October 15, 2026. The TMINI deal extension was announced on October 13, 2026.

Robotics partnership and earnings calendar

Zimmer Biomet extended its TMINI distribution agreement on October 13, 2026.
Second-quarter revenue reached USD 2.18 billion, up 4.80 percent year over year.
Zimmer Biomet stock trades at EUR 81.90 at 1:08 p.m. CEST at Lang & Schwarz on October 15, 2026.

Schwarzweiß-Reportagefoto einer Technikerin bei der Prüfung von Hüftprothesen — Zimmer Biomet US98956P1021 dokumentiert Technikerin bei Prüfung von Hüftprothesen-Komponenten in Schwarzweiß-Reportage-Aufnahme heute, Illustration mit AI erstellt.

Zimmer Biomet stock costs EUR 81.90 at Lang & Schwarz on October 15, 2026, while the company extends its exclusive TMINI distribution agreement. PR Newswire reported on October 13, 2026, that Zimmer Biomet and THINK Surgical agreed to continue the arrangement for multiple years.

Robotics deal broadens the portfolio

The agreement keeps Zimmer Biomet as the exclusive distributor of a wireless, handheld TMINI robotic system compatible with the Persona Knee System. The product partnership adds another route into robotic knee surgery while Zimmer Biomet continues developing its own ROSA platform.

What supports the growth case?

The latest reported quarter supplied a stronger financial reference point. In the second quarter of 2026, revenue reached USD 2.18 billion, up 4.80 percent year over year, while GAAP diluted earnings per share rose to USD 1.03 from USD 0.77 in the second quarter of 2025, according to the Yahoo Finance transcript. Management also raised full-year 2026 adjusted earnings per share guidance to USD 8.47-8.59 from USD 8.40-8.55.

Three dates shape the story

On August 5, 2026, Zimmer Biomet reported second-quarter revenue of USD 2.18 billion. On October 6, 2026, the company announced a November 4, 2026 release date for third-quarter results through its investor relations release. On October 13, 2026, it extended the TMINI agreement for multiple years, making the robotics partnership the latest corporate development.

When are the next key dates?

The next dividend payment is scheduled for October 30, 2026, according to MarketBeat. Zimmer Biomet has scheduled its third-quarter 2026 results for November 4, 2026, at 6:30 a.m. ET, followed by the earnings call at 8:30 a.m. ET.

Stock position for investors

Zimmer Biomet's market capitalization was USD 17.5 billion on October 14, 2026, while its NYSE listing was last quoted at USD 91.77 after hours. The company operates in healthcare and medical devices, so the next results will test whether the upgraded outlook is translating into sustained sales growth.

Zimmer Biomet was trading at EUR 81.90 at Lang & Schwarz on October 15, 2026 at 1:08 p.m. CEST. The further course of trading is shown by the continuously updated real-time quote of Zimmer Biomet stock.